112 related articles for article (PubMed ID: 2968272)
1. SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity.
Skarsfeldt T; Larsen JJ
Eur J Pharmacol; 1988 Apr; 148(3):389-95. PubMed ID: 2968272
[TBL] [Abstract][Full Text] [Related]
2. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
Skarsfeldt T; Arnt J; Hyttel J
Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
[TBL] [Abstract][Full Text] [Related]
3. The electrically-stimulated spinal reflex in pithed rats: a possible test model for evaluating blockade of central dopamine D1 and D2 receptors.
Skarsfeldt T
Pharmacol Toxicol; 1989 Mar; 64(3):298-301. PubMed ID: 2566992
[TBL] [Abstract][Full Text] [Related]
4. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
Riddall DR
Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
7. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
Bischoff S; Heinrich M; Sonntag JM; Krauss J
Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
Bischoff S; Heinrich M; Krauss J; Sills MA; Williams M; Vassout A
J Recept Res; 1988; 8(1-4):107-20. PubMed ID: 3290470
[TBL] [Abstract][Full Text] [Related]
9. In vivo binding of SCH 39166: a D-1 selective antagonist.
McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
[TBL] [Abstract][Full Text] [Related]
10. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
11. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
Meller ST; Lewis SJ; Brody MJ; Gebhart GF
Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336
[TBL] [Abstract][Full Text] [Related]
12. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Monti JM; Fernández M; Jantos H
Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
[TBL] [Abstract][Full Text] [Related]
14. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.
Longoni R; Spina L; Di Chiara G
Eur J Pharmacol; 1987 Feb; 134(2):163-73. PubMed ID: 2883010
[TBL] [Abstract][Full Text] [Related]
15. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
Edwards E; Harkins K; Ashby CR; Wang RY
J Pharmacol Exp Ther; 1991 Mar; 256(3):1025-32. PubMed ID: 1848625
[TBL] [Abstract][Full Text] [Related]
17. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.
Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA
Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
19. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors.
Neill JC; Cooper SJ
Psychopharmacology (Berl); 1989; 97(2):213-8. PubMed ID: 2498930
[TBL] [Abstract][Full Text] [Related]
20. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]